Literature DB >> 2050136

The solution structure of human transforming growth factor alpha.

T S Harvey1, A J Wilkinson, M J Tappin, R M Cooke, I D Campbell.   

Abstract

The solution structure of transforming growth factor alpha has been determined by a combination of high-resolution 1H-nuclear magnetic resonance and distance geometry and restrained molecular dynamics. The 382 restraints derived from the NMR experiments were used to calculate many distance geometry structures, which were then refined by restrained molecular mechanics. Five of these structures were further refined using a variety of methods. Comparison of independently measured parameters, such as calculated hydrogen bonding patterns and experimental amide exchange rates, have been used to evaluate the accuracy of the structures. Also, possible mechanisms to explain the pH-dependent conformational interconversion observed are suggested. Finally comparisons between this work and others on this topic have been made.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050136     DOI: 10.1111/j.1432-1033.1991.tb16050.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  The three-dimensional structure of the first EGF-like module of human factor IX: comparison with EGF and TGF-alpha.

Authors:  M Baron; D G Norman; T S Harvey; P A Handford; M Mayhew; A G Tse; G G Brownlee; I D Campbell
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

2.  Simulated annealing with restrained molecular dynamics using CONGEN: energy refinement of the NMR solution structures of epidermal and type-alpha transforming growth factors.

Authors:  R Tejero; D Bassolino-Klimas; R E Bruccoleri; G T Montelione
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

3.  High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.

Authors:  R J Goodson; M V Doyle; S E Kaufman; S Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

4.  Role of the 6-20 disulfide bridge in the structure and activity of epidermal growth factor.

Authors:  K J Barnham; A M Torres; D Alewood; P F Alewood; T Domagala; E C Nice; R S Norton
Journal:  Protein Sci       Date:  1998-08       Impact factor: 6.725

5.  Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling.

Authors:  Marisa Martin-Fernandez; David T Clarke; Mark J Tobin; Samantha V Jones; Gareth R Jones
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

6.  Combined use of 13C chemical shift and 1H alpha-13C alpha heteronuclear NOE data in monitoring a protein NMR structure refinement.

Authors:  B Celda; C Biamonti; M J Arnau; R Tejero; G T Montelione
Journal:  J Biomol NMR       Date:  1995-02       Impact factor: 2.835

7.  Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Authors:  Julie M Kneller; Thomas Ehlen; Jasenka P Matisic; Dianne Miller; Dirk Van Niekerk; Wan L Lam; Marco Marra; Rebecca Richards-Kortum; Michelle Follen; Calum Macaulay; Steven J M Jones
Journal:  Biomark Insights       Date:  2007-12-11

8.  Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.

Authors:  Qing Guo; Marika Manolopoulou; Yao Bian; Alexander B Schilling; Wei-Jen Tang
Journal:  J Mol Biol       Date:  2009-11-05       Impact factor: 5.469

9.  Thrombin-binding affinities of different disulfide-bonded isomers of the fifth EGF-like domain of thrombomodulin.

Authors:  M J Hunter; E A Komives
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

10.  The kinetics of the hydrogen/deuterium exchange of epidermal growth factor receptor ligands.

Authors:  Ibon Iloro; Daniel Narváez; Nancy Guillén; Carlos M Camacho; Lalisse Guillén; Elsa Cora; Belinda Pastrana-Ríos
Journal:  Biophys J       Date:  2008-01-16       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.